ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 143 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $24,518,000 | +33.3% | 1,300,000 | -16.8% | 0.98% | +46.9% |
| Q2 2019 | $18,388,000 | -13.6% | 1,562,300 | +0.1% | 0.66% | -19.0% |
| Q1 2019 | $21,294,000 | +40.8% | 1,560,000 | +5.8% | 0.82% | +15.0% |
| Q4 2018 | $15,119,000 | -44.4% | 1,475,000 | -9.6% | 0.71% | -27.4% |
| Q3 2018 | $27,181,000 | +9.9% | 1,632,500 | +4.3% | 0.98% | +3.5% |
| Q2 2018 | $24,727,000 | +27.3% | 1,565,000 | +2.3% | 0.95% | +14.7% |
| Q1 2018 | $19,428,000 | +60.8% | 1,529,800 | +45.0% | 0.83% | +51.3% |
| Q4 2017 | $12,080,000 | +12.7% | 1,055,000 | +20.6% | 0.55% | +10.7% |
| Q3 2017 | $10,719,000 | +414.3% | 875,000 | +380.8% | 0.50% | +371.4% |
| Q2 2017 | $2,084,000 | -45.0% | 182,000 | 0.0% | 0.10% | -51.8% |
| Q1 2017 | $3,786,000 | 0.0% | 182,000 | 0.0% | 0.22% | -13.8% |
| Q4 2016 | $3,786,000 | -36.5% | 182,000 | 0.0% | 0.25% | -32.4% |
| Q3 2016 | $5,964,000 | +32.3% | 182,000 | +0.8% | 0.37% | +12.0% |
| Q2 2016 | $4,507,000 | +88.7% | 180,500 | +85.1% | 0.33% | +67.0% |
| Q1 2016 | $2,388,000 | – | 97,500 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |